Companies still to respond to FDA on Y2K status:
This article was originally published in Clinica
Around 150 manufacturers have not yet provided data to the FDA's clearinghouse on the Year 2000 compliance status of their products. A further 300 or so have provided information that is either incomplete or requires clarification, according to the agency, which says it will now have to extend its Y2K information collection activity until the end of February next year. The FDA estimates it will take manufacturers an average of eight hours to collect, prepare and submit the requested information.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.